These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
CAYMAN ISLANDS
|
N/A
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. employer identification no.)
|
|
65 MARKET STREET
SUITE 1207, CAMANA BAY
P.O. BOX 31110
GRAND CAYMAN
CAYMAN ISLANDS
|
KY1-1205
|
|
(Address of principal executive offices)
|
(Zip code)
|
|
Class A Ordinary Shares, $0.10 par value
|
30,200,835
|
|
Class B Ordinary Shares, $0.10 par value
|
6,254,949
|
|
(Class)
|
(Outstanding as of October 29, 2010)
|
|
Page
|
|||||
|
PART I — FINANCIAL INFORMATION
|
|||||
|
Item 1.
|
|||||
|
3
|
|||||
|
4
|
|||||
|
5
|
|||||
|
6
|
|||||
|
7
|
|||||
|
Item 2.
|
19
|
||||
|
Item 3.
|
29
|
||||
|
Item 4.
|
30
|
||||
|
PART II — OTHER INFORMATION
|
|||||
|
Item 1.
|
31
|
||||
|
Item 1A.
|
31
|
||||
|
Item 2.
|
32
|
||||
|
Item 3.
|
32
|
||||
|
Item 4.
|
32
|
||||
|
Item 5.
|
32
|
||||
|
Item 6.
|
32
|
||||
|
|
|||||
|
September
30,
2010
(unaudited)
|
December 31, 2009
|
||||||||
|
Assets
|
|||||||||
|
Investments
|
|||||||||
|
Debt instruments, trading, at fair value
|
$
|
20,060
|
$
|
95,838
|
|||||
|
Equity securities, trading, at fair value
|
744,292
|
593,201
|
|||||||
|
Other investments, at fair value
|
172,936
|
141,561
|
|||||||
|
Total investments
|
937,288
|
830,600
|
|||||||
|
Cash and cash equivalents
|
9,726
|
31,717
|
|||||||
|
Restricted cash and cash equivalents
|
631,758
|
590,871
|
|||||||
|
Financial contracts receivable, at fair value
|
16,491
|
30,117
|
|||||||
|
Reinsurance balances receivable
|
147,745
|
82,748
|
|||||||
|
Loss and loss adjustment expense recoverable
|
9,518
|
7,270
|
|||||||
|
Deferred acquisition costs, net
|
85,172
|
34,401
|
|||||||
|
Unearned premiums ceded
|
6,325
|
6,478
|
|||||||
|
Notes receivable
|
14,491
|
15,424
|
|||||||
|
Other assets
|
2,947
|
4,754
|
|||||||
|
Total assets
|
$
|
1,861,461
|
$
|
1,634,380
|
|||||
|
Liabilities and shareholders’ equity
|
|||||||||
|
Liabilities
|
|||||||||
|
Securities sold, not yet purchased, at fair value
|
$
|
578,790
|
$
|
570,875
|
|||||
|
Financial contracts payable, at fair value
|
25,653
|
16,200
|
|||||||
|
Due to prime brokers
|
22,822
|
—
|
|||||||
|
Loss and loss adjustment expense reserves
|
161,180
|
137,360
|
|||||||
|
Unearned premium reserves
|
233,491
|
118,899
|
|||||||
|
Reinsurance balances payable
|
35,239
|
34,301
|
|||||||
|
Funds withheld
|
22,482
|
14,711
|
|||||||
|
Other liabilities
|
10,859
|
12,796
|
|||||||
|
Performance compensation payable to related party
|
4,145
|
—
|
|||||||
|
Total liabilities
|
1,094,661
|
905,142
|
|||||||
|
Shareholders’ equity
|
|||||||||
|
Preferred share capital (par value $0.10; authorized, 50,000,000; none issued)
|
—
|
—
|
|||||||
|
Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 30,200,835 (2009: 30,063,893); Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,949 (2009: 6,254,949))
|
3,646
|
3,632
|
|||||||
|
Additional paid-in capital
|
484,535
|
481,449
|
|||||||
|
Non-controlling interest in joint venture
|
30,784
|
30,597
|
|||||||
|
Retained earnings
|
247,835
|
213,560
|
|||||||
|
Total shareholders’ equity
|
766,800
|
729,238
|
|||||||
|
Total liabilities and shareholders’ equity
|
$
|
1,861,461
|
$
|
1,634,380
|
|||||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
|||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||
|
Revenues
|
||||||||||
|
Gross premiums written
|
$
|
151,247
|
$
|
65,983
|
$
|
307,091
|
$
|
207,901
|
||
|
Gross premium ceded
|
(3,639
|
) |
(2,894
|
) |
(8,228
|
) |
(10,725
|
)
|
||
|
Net premium written
|
147,608
|
63,089
|
298,863
|
197,176
|
||||||
|
Change in net unearned premium reserves
|
(68,207
|
) |
(6,432
|
) |
(114,745
|
) |
(44,979
|
) | ||
|
Net premiums earned
|
79,401
|
56,657
|
184,118
|
152,197
|
||||||
|
Net investment income
|
33,881
|
32,628
|
39,682
|
148,667
|
||||||
|
Other income (expense), net
|
(474
|
) |
(145
|
) |
(1,002
|
) |
1,909
|
|||
|
Total revenues
|
112,808
|
89,140
|
222,798
|
302,773
|
||||||
|
Expenses
|
||||||||||
|
Loss and loss adjustment expenses incurred, net
|
50,257
|
34,643
|
114,936
|
88,386
|
||||||
|
Acquisition costs, net
|
28,807
|
17,767
|
60,183
|
46,591
|
||||||
|
General and administrative expenses
|
3,392
|
4,081
|
11,633
|
13,788
|
||||||
|
Total expenses
|
82,456
|
56,491
|
186,752
|
148,765
|
||||||
|
Net income before non-controlling interest and income tax expense
|
30,352
|
32,649
|
36,046
|
154,008
|
||||||
|
Non-controlling interest in income of joint venture
|
(1,313
|
) |
(380
|
) |
(1,687
|
) |
(1,716
|
) | ||
|
Net income before income tax expense
|
29,039
|
32,269
|
34,359
|
152,292
|
||||||
|
Income tax expense
|
(25
|
) |
(11
|
) |
(84
|
) |
(28
|
) | ||
|
Net income
|
$
|
29,014
|
$
|
32,258
|
$
|
34,275
|
$
|
152,264
|
||
|
Earnings per share
|
||||||||||
|
Basic
|
$
|
0.80
|
$
|
0.89
|
$
|
0.94
|
$
|
4.21
|
||
|
Diluted
|
$
|
0.78
|
$
|
0.88
|
$
|
0.92
|
$
|
4.16
|
||
|
Weighted average number of ordinary shares used in the determination of:
|
||||||||||
|
Basic
|
36,452,224
|
36,286,514
|
36,408,859
|
36,202,860
|
||||||
|
Diluted
|
37,218,906
|
36,828,726
|
37,174,558
|
36,627,849
|
||||||
|
Nine months ended
September 30, 2010
|
Nine months ended
September 30, 2009
|
|||||||
|
Ordinary share capital
|
||||||||
|
Balance – beginning of period
|
$
|
3,632
|
$
|
3,604
|
||||
|
Issue of Class A ordinary share capital, net of forfeitures
|
14
|
27
|
||||||
|
Balance – end of period
|
$
|
3,646
|
$
|
3,631
|
||||
|
Additional paid-in capital
|
||||||||
|
Balance – beginning of period
|
$
|
481,449
|
$
|
477,571
|
||||
|
Issue of Class A ordinary share capital
|
32
|
578
|
||||||
|
Share-based compensation expense, net of forfeitures
|
3,054
|
2,528
|
||||||
|
Options repurchased
|
—
|
(124
|
) | |||||
|
Balance – end of period
|
$
|
484,535
|
$
|
480,553
|
||||
|
Non-controlling interest
|
||||||||
|
Balance – beginning of period
|
$
|
30,597
|
$
|
6,058
|
||||
|
Non-controlling interest (withdrawal) contribution from/to joint venture
|
(1,500
|
) |
337
|
|||||
|
Non-controlling interest in income of joint venture
|
1,687
|
1,716
|
||||||
|
Balance – end of period
|
$
|
30,784
|
$
|
8,111
|
||||
|
Retained earnings
|
||||||||
|
Balance – beginning of period
|
$
|
213,560
|
$
|
4,207
|
||||
|
Net income
|
34,275
|
152,264
|
||||||
|
Options repurchased
|
—
|
(89
|
) | |||||
|
Balance – end of period
|
$
|
247,835
|
$
|
156,382
|
||||
|
Total shareholders’ equity
|
$
|
766,800
|
$
|
648,677
|
||||
|
Nine months ended September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
Cash provided by (used in)
Operating activities
|
||||||||
|
Net income
|
$
|
34,275
|
$
|
152,264
|
||||
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities
|
||||||||
|
Net change in unrealized gains and losses on investments and financial contracts
|
1,258
|
(164,936
|
) | |||||
|
Net realized gains on investments and financial contracts
|
(52,153
|
) |
(8,073
|
) | ||||
|
Foreign exchange (gain) loss on restricted cash and cash equivalents
|
(3,810
|
) |
2,164
|
|||||
|
Non-controlling interest in income of joint venture
|
1,687
|
1,716
|
||||||
|
Share-based compensation expense
|
3,068
|
2,549
|
||||||
|
Depreciation expense
|
168
|
60
|
||||||
|
Net change in
|
||||||||
|
Reinsurance balances receivable
|
(64,997
|
) |
(27,519
|
) | ||||
|
Loss and loss adjustment expense recoverable
|
(2,248
|
) |
5,011
|
|||||
|
Deferred acquisition costs, net
|
(50,771
|
) |
(19,551
|
) | ||||
|
Unearned premiums ceded
|
153
|
(452
|
) | |||||
|
Other assets
|
1,639
|
(1,763
|
) | |||||
|
Loss and loss adjustment expense reserves
|
23,820
|
50,186
|
||||||
|
Unearned premium reserves
|
114,592
|
45,432
|
||||||
|
Reinsurance balances payable
|
938
|
1,251
|
||||||
|
Funds withheld
|
7,771
|
(369
|
) | |||||
|
Other liabilities
|
(1,937
|
) |
3,819
|
|||||
|
Performance compensation payable to related party
|
4,145
|
16,255
|
||||||
|
Net cash provided by operating activities
|
$
|
17,598
|
$
|
58,044
|
||||
|
Investing activities
|
||||||||
|
Purchase of investments and financial contracts
|
(885,146
|
) |
(890,780
|
) | ||||
|
Sales of investments and financial contracts
|
860,347
|
1,024,623
|
||||||
|
Change in due to prime brokers
|
22,822
|
—
|
||||||
|
Change in restricted cash and cash equivalents, net
|
(37,077
|
) |
(247,589
|
) | ||||
|
Change in notes receivable, net
|
933
|
(14,383
|
) | |||||
|
Non-controlling interest (withdrawal) contribution from/to joint venture
|
(1,500
|
) |
337
|
|||||
|
Fixed assets additions
|
—
|
(1,453
|
) | |||||
|
Net cash used in investing activities
|
$
|
(39,621
|
) |
$
|
(129,245
|
) | ||
|
Financing activities
|
||||||||
|
Net proceeds from exercising of stock options
|
32
|
584
|
||||||
|
Options repurchased
|
—
|
(213
|
) | |||||
|
Net cash provided by financing activities
|
$
|
32
|
|
$
|
371
|
|||
|
Net decrease in cash and cash equivalents
|
(21,991
|
) |
(70,830
|
) | ||||
|
Cash and cash equivalents at beginning of period
|
31,717
|
94,144
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
9,726
|
$
|
23,314
|
||||
|
Supplementary information
|
||||||||
|
Interest paid in cash
|
$
|
7,840
|
$
|
3,430
|
||||
|
Interest received in cash
|
3,880
|
3,500
|
||||||
|
Income tax paid in cash
|
17
|
—
|
||||||
|
1.
|
GENERAL
|
|
2.
|
SIGNIFICANT ACCOUNTING POLICIES
|
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
||||||||
|
2010
|
2009
|
2010
|
2009
|
||||||
|
Weighted average shares outstanding
|
36,452,224
|
36,286,514
|
36,408,859
|
36,202,860
|
|||||
|
Effect of dilutive service provider share-based awards
|
177,559
|
148,729
|
178,483
|
125,767
|
|||||
|
Effect of dilutive employee and director share-based awards
|
589,123
|
393,483
|
587,216
|
299,222
|
|||||
|
37,218,906
|
36,828,726
|
37,174,558
|
36,627,849
|
||||||
|
Anti-dilutive stock options outstanding
|
240,000
|
210,000
|
240,000
|
210,000
|
|||||
|
3.
|
FINANCIAL INSTRUMENTS
|
|
|
Fair value measurements as of September 30, 2010
|
|||||||||||||||
|
Description
|
Quoted prices in
active markets
(Level 1)
|
Significant other
observable
inputs
(Level 2)
|
Significant
unobservable
inputs
(Level 3)
|
Total
|
||||||||||||
|
($ in thousands)
|
||||||||||||||||
|
Assets:
|
||||||||||||||||
|
Debt instruments
|
$
|
—
|
$
|
16,813
|
$
|
3,247
|
$
|
20,060
|
||||||||
|
Listed equity securities
|
744,292
|
—
|
—
|
744,292
|
||||||||||||
|
Commodities
|
122,195
|
—
|
—
|
122,195
|
||||||||||||
|
Private and unlisted equity securities
|
—
|
1,892
|
39,630
|
41,522
|
||||||||||||
|
Put options
|
—
|
5,533
|
—
|
5,533
|
||||||||||||
|
Call options
|
—
|
3,686
|
—
|
3,686
|
||||||||||||
|
Financial contracts receivable
|
—
|
16,064
|
427
|
16,491
|
||||||||||||
|
$
|
866,487
|
$
|
43,988
|
$
|
43,304
|
$
|
953,779
|
|||||||||
|
Liabilities:
|
||||||||||||||||
|
Debt instruments, sold not yet purchased
|
$
|
—
|
$
|
(1,871
|
) |
$
|
—
|
$
|
(1,871
|
) | ||||||
|
Listed equity securities, sold not yet purchased
|
(576,394
|
) |
—
|
—
|
(576,394
|
) | ||||||||||
|
Call options
|
—
|
(525
|
) |
—
|
(525
|
) | ||||||||||
|
Financial contracts payable
|
—
|
(25,653
|
) |
—
|
(25,653
|
) | ||||||||||
|
$
|
(576,394
|
) |
$
|
(28,049
|
) |
$
|
—
|
$
|
(604,443
|
) | ||||||
|
Fair value measurements as of December 31, 2009
|
||||||||||||||||
|
Description
|
Quoted prices in
active markets
(Level 1)
|
Significant other
observable
inputs
(Level 2)
|
Significant
unobservable
inputs
(Level 3)
|
Total
|
||||||||||||
|
($ in thousands)
|
||||||||||||||||
|
Assets:
|
||||||||||||||||
|
Debt instruments
|
$
|
—
|
$
|
94,301
|
$
|
1,537
|
$
|
95,838
|
||||||||
|
Listed equity securities
|
593,201
|
—
|
—
|
593,201
|
||||||||||||
|
Commodities
|
102,239
|
—
|
—
|
102,239
|
||||||||||||
|
Private and unlisted equity securities
|
—
|
—
|
25,228
|
25,228
|
||||||||||||
|
Put options
|
—
|
8,809
|
—
|
8,809
|
||||||||||||
|
Call options
|
—
|
5,285
|
—
|
5,285
|
||||||||||||
|
Financial contracts receivable
|
—
|
30,117
|
—
|
30,117
|
||||||||||||
|
$
|
695,440
|
$
|
138,512
|
$
|
26,765
|
$
|
860,717
|
|||||||||
|
Liabilities:
|
||||||||||||||||
|
Listed equity securities, sold not yet purchased
|
$
|
(570,875
|
)
|
$
|
—
|
$
|
—
|
$
|
(570,875
|
)
|
||||||
|
Financial contracts payable
|
—
|
(16,200
|
)
|
—
|
(16,200
|
)
|
||||||||||
|
$
|
(570,875
|
)
|
$
|
(16,200
|
)
|
$
|
—
|
$
|
(587,075
|
)
|
||||||
|
Fair value measurements using
significant unobservable inputs
(Level 3)
Three months ended September 30, 2010
|
Fair value measurements using
significant unobservable inputs
(Level 3)
Nine months ended September 30, 2010
|
|||||||||||||||||||||||
|
Debt
instruments
|
Private
and unlisted equity
securities
|
Financial contracts receivable
|
Total
|
Debt
instruments
|
Private
and unlisted equity
securities
|
Financial contracts receivable
|
Total
|
|||||||||||||||||
|
($ in thousands)
|
||||||||||||||||||||||||
|
Beginning balance
|
$
|
1,090
|
$
|
36,924
|
$
|
641
|
$
|
38,655
|
$
|
1,537
|
$
|
25,228
|
$
|
—
|
$
|
26,765
|
||||||||
|
Purchases, sales, issuances, and settlements, net
|
1,575
|
|
2,452
|
|
—
|
4,027
|
|
1,563
|
|
12,567
|
855
|
14,985
|
||||||||||||
|
Total realized and unrealized gains (losses) and amortization included in earnings, net
|
582
|
|
254
|
(214
|
)
|
622
|
147
|
|
1,835
|
(428
|
)
|
1,554
|
||||||||||||
|
Transfers into (out of) Level 3, net
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
||||||||||||||||
|
Ending balance,
September
30, 2010
|
$
|
3,247
|
$
|
39,630
|
$
|
427
|
$
|
43,304
|
$
|
3,247
|
$
|
39,630
|
$
|
427
|
$
|
43,304
|
||||||||
|
Fair value measurements using
significant unobservable inputs
(Level 3)
Three months ended September 30, 2009
|
Fair value measurements using
significant unobservable inputs
(Level 3)
Nine months ended September 30, 2009
|
||||||||||||||||||||
|
Debt
instruments
|
Private
and unlisted
equity
securities
|
Total |
Debt
instruments
|
Private
and unlisted
equity
securities
|
Total
|
||||||||||||||||
|
($ in thousands)
|
|||||||||||||||||||||
|
Beginning balance
|
$
|
6,806
|
$
|
9,530
|
$ |
16,336
|
$
|
4,115
|
$
|
11,776
|
$
|
15,891
|
|||||||||
|
Purchases, sales, issuances, and settlements, net
|
(3,231
|
)
|
3,140
|
(91
|
)
|
(1,481
|
)
|
3,259
|
1,778
|
||||||||||||
|
Total realized and unrealized gains (losses) included in earnings, net
|
129
|
2,196
|
2,325
|
(718
|
) |
(169
|
)
|
(887
|
)
|
||||||||||||
|
Transfers into Level 3, net
|
—
|
1,606
|
1,606
|
1,788
|
1,606
|
3,394
|
|||||||||||||||
|
Ending balance, September 30, 2009
|
$
|
3,704
|
$
|
16,472
|
$ |
20,176
|
$
|
3,704
|
$
|
16,472
|
$
|
20,176
|
|||||||||
|
2010
|
Cost/amortized
cost
|
Unrealized
gains
|
Unrealized
losses
|
Fair
value
|
||||||||||||
|
($ in thousands)
|
||||||||||||||||
|
Corporate debt – U.S.
|
$
|
18,492
|
$
|
5,944
|
$
|
(4,379
|
)
|
$
|
20,057
|
|||||||
|
Corporate debt – Non U.S.
|
16
|
—
|
(13
|
)
|
3
|
|||||||||||
|
Total debt instruments
|
$
|
18,508
|
$
|
5,944
|
$
|
(4,392)
|
$
|
20,060
|
||||||||
|
2009
|
Cost / amortized
cost
|
Unrealized
gains
|
Unrealized
losses
|
Fair
value
|
||||||||||||
|
($ in thousands)
|
||||||||||||||||
|
Corporate debt – U.S.
|
|
$ |
60,121
|
$
|
36,040
|
$
|
(5,555
|
) |
$
|
90,606
|
||||||
|
Corporate debt – Non U.S.
|
2,961
|
2,274
|
(3
|
) |
5,232
|
|||||||||||
|
Total debt instruments
|
|
$ |
63,082
|
$
|
38,314
|
$
|
(5,558
|
) |
$
|
95,838
|
||||||
|
Cost / amortized
cost
|
Fair
value
|
|||||||
|
($ in thousands)
|
||||||||
|
Within one year
|
$
|
4,223
|
$
|
5,066
|
||||
|
From one to five years
|
7,860
|
12,010
|
||||||
|
From five to ten years
|
3,947
|
1,602
|
||||||
|
More than ten years
|
2,478
|
1,382
|
||||||
|
$
|
18,508
|
$
|
20,060
|
|||||
|
2010
|
Cost
|
Unrealized
gains
|
Unrealized
losses
|
Fair
value
|
||||||||||||
|
($ in thousands)
|
||||||||||||||||
|
Equities – listed
|
$
|
652,760
|
$
|
105,942
|
$
|
(34,075
|
)
|
$
|
724,627
|
|||||||
|
Exchange traded funds
|
7,002
|
12,663
|
—
|
19,665
|
||||||||||||
|
$
|
659,762
|
$
|
118,605
|
$
|
(34,075
|
)
|
$
|
744,292
|
||||||||
|
2009
|
Cost
|
Unrealized
gains
|
Unrealized
losses
|
Fair
value
|
||||||||||||
|
($ in thousands)
|
||||||||||||||||
|
Equities – listed
|
$
|
510,229
|
$
|
104,768
|
$
|
(40,040
|
) |
$
|
574,957
|
|||||||
|
Exchange traded funds
|
7,879
|
10,365
|
—
|
18,244
|
||||||||||||
|
$
|
518,108
|
$
|
115,133
|
$
|
(40,040
|
) |
$
|
593,201
|
||||||||
|
2010
|
Cost
|
Unrealized
gains
|
Unrealized
losses
|
Fair
value
|
|||||||||
|
($ in thousands)
|
|||||||||||||
|
Commodities
|
$
|
96,551
|
$
|
25,644
|
$
|
—
|
$
|
122,195
|
|||||
|
Private and unlisted equity securities
|
42,532
|
1,877
|
(2,887
|
)
|
41,522
|
||||||||
|
Put options
|
16,044
|
—
|
(10,511
|
)
|
5,533
|
||||||||
|
Call options
|
4,252
|
—
|
(566
|
)
|
3,686
|
||||||||
|
$
|
159,379
|
$
|
27,521
|
$
|
(13,964
|
)
|
$
|
172,936
|
|||||
|
2009
|
Cost
|
Unrealized
gains
|
Unrealized
losses
|
Fair
value
|
||||||||||||
|
($ in thousands)
|
||||||||||||||||
|
Commodities
|
$
|
96,552
|
$
|
5,687
|
$
|
—
|
$
|
102,239
|
||||||||
|
Private and unlisted equity securities
|
27,636
|
1,430
|
(3,838
|
)
|
25,228
|
|||||||||||
|
Put options
|
6,269
|
2,540
|
—
|
8,809
|
||||||||||||
|
Call options
|
6,406
|
51
|
(1,172
|
)
|
5,285
|
|||||||||||
|
$
|
136,863
|
$
|
9,708
|
$
|
(5,010
|
)
|
$
|
141,561
|
||||||||
| 2010 |
Proceeds
|
Unrealized gains
|
Unrealized losses
|
Fair
value
|
|||||||||
|
($ in thousands)
|
|||||||||||||
|
Equities – listed
|
$
|
(561,218
|
)
|
$
|
78,343
|
$
|
(69,945
|
)
|
$
|
(552,820
|
)
|
||
|
Warrants and rights on listed equities
|
—
|
—
|
(538
|
)
|
(538
|
)
|
|||||||
|
Exchange traded funds
|
(21,601
|
)
|
—
|
(1,435
|
)
|
(23,036
|
)
|
||||||
|
Debt instruments
|
(1,870
|
)
|
3
|
(4
|
)
|
(1,871
|
)
|
||||||
|
Call options
|
(827
|
)
|
302
|
—
|
(525
|
)
|
|||||||
|
$
|
(585,516
|
)
|
$
|
78,648
|
$
|
(71,922
|
)
|
$
|
(578,790
|
)
|
|||
| 2009 |
Proceeds
|
Unrealized gains
|
Unrealized losses
|
Fair
value
|
||||||||||
|
($ in thousands)
|
||||||||||||||
|
Equities - listed
|
$
|
(536,895
|
)
|
$
|
62,278
|
$
|
(79,525
|
)
|
$
|
(554,142
|
)
|
|||
|
Warrants and rights on listed equities
|
—
|
—
|
(733
|
)
|
(733
|
)
|
||||||||
|
Exchange traded funds
|
(15,678
|
)
|
—
|
(322
|
)
|
(16,000
|
)
|
|||||||
|
$
|
(552,573
|
)
|
$
|
62,278
|
$
|
(80,580
|
)
|
$
|
(570,875
|
)
|
||||
|
Financial contracts
|
Listing
currency
|
Notional amount of
underlying instruments
|
Fair value of net assets
(obligations)
on financial
contracts
|
||||
|
($ in thousands)
|
|||||||
|
Financial contracts receivable
|
|||||||
|
Interest rate options
|
USD
|
1,723,954
|
$
|
4,976
|
|||
|
Credit default swaps, purchased – sovereign debt
|
USD
|
117,353
|
4,870
|
||||
|
Credit default swaps, purchased – corporate debt
|
USD
|
180,926
|
239
|
||||
|
Total return swaps – equities
|
USD
|
45,390
|
5,979
|
||||
|
Weather derivative swap
|
USD
|
10,000
|
427
|
||||
|
Total financial contracts receivable, at fair value
|
$
|
16,491
|
|||||
|
Financial contracts payable
|
|||||||
|
Credit default swaps, purchased – sovereign debt
|
USD
|
189,898
|
$
|
(3,456
|
)
|
||
|
Credit default swaps, purchased – corporate debt
|
USD
|
81,453
|
(4,801
|
)
|
|||
|
Credit default swaps, issued – corporate debt
|
USD
|
35,890
|
(15,963
|
)
|
|||
|
Total return swaps – equities
|
USD
|
13,410
|
(1,433
|
)
|
|||
|
Total financial contracts payable, at fair value
|
$
|
(25,653
|
)
|
||||
|
Financial contracts
|
Listing
currency
|
Notional amount of
underlying instruments
|
Fair value of net assets (obligations) on financial contracts | ||||||
|
($ in thousands)
|
|||||||||
|
Financial contracts receivable
|
|||||||||
|
Interest rate options
|
USD | 1,723,954 |
$
|
20,325
|
|||||
|
Credit default swaps, purchased – sovereign debt
|
USD | 315,722 |
5,322
|
||||||
|
Total return swaps – equities
|
USD | 45,516 |
4,470
|
||||||
|
Total financial contracts receivable, at fair value
|
$
|
30,117
|
|||||||
|
Financial contracts payable
|
|||||||||
|
Credit default swaps, purchased – sovereign debt
|
USD | 20,811 |
$
|
(128
|
)
|
||||
|
Credit default swaps, purchased – corporate debt
|
USD | 121,118 |
(7,281
|
)
|
|||||
|
Credit default swaps, issued – corporate debt
|
USD | 13,909 |
(8,739
|
)
|
|||||
|
Total return swaps – equities
|
USD | 2,286 |
(52
|
)
|
|||||
|
Total financial contracts payable, at fair value
|
$
|
(16,200
|
)
|
||||||
|
Derivatives not designated as hedging instruments
|
Location of gains and losses on derivatives recognized in income
|
Gain (loss) on derivatives recognized in
income for the three months ended
September 30,
|
Gain (loss) on derivatives recognized in income for the nine months ended September 30,
|
|||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
($ in thousands)
|
($ in thousands)
|
|||||||||||||||
|
Interest rate options
|
Net investment income
|
$
|
(2,047
|
)
|
$
|
(3,199
|
) |
(15,350
|
)
|
$
|
2,608
|
|||||
|
Credit default swaps, purchased – corporate debt
|
Net investment income
|
(3,205
|
)
|
(7,189
|
) |
(677
|
)
|
(13,425
|
) | |||||||
|
Credit default swaps, purchased – sovereign debt
|
Net investment income
|
(2,127
|
)
|
(3,233
|
) |
5,795
|
|
(12,829
|
) | |||||||
|
Total return swaps – equities
|
Net investment income
|
3,579
|
2,090
|
5,194
|
3,992
|
|||||||||||
|
Credit default swaps, issued – corporate debt
|
Net investment income
|
2,571
|
802
|
3,338
|
(1,008
|
) | ||||||||||
|
Options, futures, warrants, and rights
|
Net investment income
|
(10,585
|
)
|
(3,097
|
) |
(19,075
|
)
|
(10,010
|
) | |||||||
|
Weather derivative swap
|
Other income (expense) |
(214
|
)
|
— |
(428
|
)
|
— | |||||||||
|
Total
|
$
|
(12,028
|
)
|
$
|
(13,826
|
) |
$
|
(21,203
|
)
|
$
|
(30,672
|
) | ||||
|
Derivatives not designated as hedging instruments
|
Three months ended
September 30, 2010
|
Nine months ended
September 30, 2010
|
|||||||||||
|
Entered
|
Exited
|
Entered
|
Exited
|
||||||||||
|
($ in thousands)
|
|||||||||||||
|
Credit default swaps
|
$
|
21,981
|
$
|
—
|
$
|
340,106
|
$
|
206,145
|
|||||
|
Total return swaps
|
4,372
|
12,905
|
34,471
|
17,323
|
|||||||||
|
Weather derivative swap
|
—
|
—
|
10,000
|
—
|
|||||||||
|
Options
|
188,528
|
57,999
|
510,929
|
199,582
|
|||||||||
|
Futures
|
—
|
—
|
44,436
|
41,762
|
|||||||||
|
Total
|
$
|
214,881
|
$
|
70,904
|
$
|
939,942
|
$
|
464,812
|
|||||
|
Three months ended
September 30, 2009
|
Nine months ended
September 30, 2009
|
||||||||||||
|
Derivatives not designated as hedging instruments
|
Entered
|
Exited
|
Entered
|
Exited
|
|||||||||
|
($ in thousands)
|
|||||||||||||
|
Credit default swaps
|
$
|
—
|
$
|
151
|
$
|
164,421
|
$
|
21,000
|
|||||
|
Total return swaps
|
—
|
8,713
|
—
|
20,857
|
|||||||||
|
Interest rate options
|
416,693
|
—
|
1,319,863
|
—
|
|||||||||
|
Options
|
86,268
|
38,458
|
214,068
|
60,486
|
|||||||||
|
Rights – equity
|
—
|
—
|
7,870
|
4,212
|
|||||||||
|
Total
|
$
|
502,961
|
$
|
47,322
|
$
|
1,706,222
|
$
|
106,555
|
|||||
|
5.
|
RETROCESSION
|
|
Number of non-vested
restricted shares
|
Weighted average
grant date fair value
|
|||||||
|
Balance at December 31, 2009
|
474,782
|
$
|
16.51
|
|||||
|
Granted
|
135,500
|
24.62
|
||||||
|
Vested
|
(140,285
|
)
|
16.02
|
|||||
|
Forfeited
|
(898
|
)
|
16.17
|
|||||
|
Balance at September 30, 2010
|
469,099
|
|
19.00
|
|||||
|
2010
|
2009
|
||||||||
|
Risk free rate
|
2.94
|
%
|
3.55
|
%
|
|||||
|
Estimated volatility
|
35.00
|
%
|
30.00
|
%
|
|||||
|
Expected term
|
10.00
|
years
|
10.00
|
years
|
|||||
|
Dividend yield
|
0.00
|
%
|
0.00
|
%
|
|||||
|
Number of options
|
Weighted average
exercise price
|
Weighted average
grant date fair value
|
||||||||||
|
Balance at December 31, 2009
|
1,281,340
|
$ |
14.24
|
$ |
6.33
|
|||||||
|
Granted
|
80,000
|
32.42
|
10.39
|
|||||||||
|
Exercised
|
(2,340
|
) |
13.85
|
7.13
|
||||||||
|
Forfeited
|
—
|
—
|
—
|
|||||||||
|
Expired
|
—
|
—
|
—
|
|||||||||
|
Balance at September 30, 2010
|
1,359,000
|
$ |
15.31
|
$ |
6.57
|
|||||||
|
Nine months ended
September 30, 2010
|
Nine months ended
September 30, 2009
|
|||||||||||||||
|
Class A
|
Class B
|
Class A
|
Class B
|
|||||||||||||
|
Balance – beginning of period
|
30,063,893
|
6,254,949
|
29,781,736
|
6,254,949
|
||||||||||||
|
Issue of ordinary shares, net of forfeitures
|
136,942
|
—
|
272,157
|
—
|
||||||||||||
|
Balance – end of period
|
30,200,835
|
6,254,949
|
30,053,893
|
6,254,949
|
||||||||||||
|
8.
|
COMMITMENTS AND CONTINGENCIES
|
|
2010
|
2011
|
2012
|
2013
|
2014
|
Thereafter
|
Total
|
||||||||||||||||
|
($ in thousands)
|
||||||||||||||||||||||
|
Operating lease obligations
|
$
|
69
|
$ |
276
|
$ |
276
|
$ |
276
|
$ |
276
|
$ |
967
|
$ |
2,140
|
||||||||
|
Specialist service agreement
|
222
|
694
|
400
|
150
|
—
|
—
|
1,466
|
|||||||||||||||
|
Private equity and limited partnerships
(1)
|
10,011
|
—
|
—
|
—
|
—
|
—
|
10,011
|
|||||||||||||||
|
$
|
10,302
|
$ |
970
|
$ |
676
|
$ |
426
|
$ |
276
|
$ |
967
|
$ |
13,617
|
|
||||||||
|
(1)
|
Given the nature of these investments, the Company is unable to determine with any degree of accuracy when these commitments will be called. Therefore, for purposes of the above table, the Company has assumed that all commitments with no fixed payment schedules will be called during the year ending December 31, 2010.
|
|
Available
|
Termination Date
|
Notice period required for termination
|
||||||||
|
($ in thousands)
|
||||||||||
|
Citibank Europe plc
|
$
|
400,000
|
October 11, 2011
|
120 days prior to termination date
|
||||||
|
Butterfield Bank (Cayman) Limited
|
60,000
|
June 30, 2011
|
90 days prior to termination date
|
|||||||
|
Bank of America, N.A
|
100,000
|
July 20, 2011
|
90 days prior to termination date
|
|||||||
|
$
|
560,000
|
|||||||||
|
9.
|
SEGMENT REPORTING
|
|
Three months ended
September 30, 2010
|
Three months ended
September 30, 2009
|
Nine months ended
September 30, 2010
|
Nine months ended
September 30, 2009
|
|||||||||||||||||
|
($ in thousands)
|
($ in thousands)
|
($ in thousands)
|
($ in thousands)
|
|||||||||||||||||
|
Property
|
||||||||||||||||||||
|
Commercial lines
|
$
|
6,052
|
4.0
|
%
|
$
|
3,800
|
5.7
|
%
|
$
|
15,468
|
5.0
|
%
|
$
|
12,363
|
6.0
|
%
|
||||
|
Personal lines
|
90,291
|
59.7
|
10,948
|
16.6
|
135,904
|
44.3
|
42,479
|
20.4
|
||||||||||||
|
Total Property
|
96,343
|
63.7
|
14,748
|
22.3
|
151,372
|
49.3
|
54,842
|
26.4
|
||||||||||||
|
Casualty
|
||||||||||||||||||||
|
General liability
|
14,510
|
9.6
|
6,770
|
10.3
|
29,609
|
9.6
|
20,933
|
10.1
|
||||||||||||
|
Marine liability
|
—
|
—
|
—
|
—
|
483
|
0.2
|
—
|
—
|
||||||||||||
|
Motor liability
|
12,712
|
8.4
|
31,495
|
47.7
|
42,294
|
13.8
|
73,448
|
35.3
|
||||||||||||
|
Motor physical damage
|
531
|
0.3
|
—
|
—
|
1,924
|
0.6
|
—
|
—
|
||||||||||||
|
Professional liability
|
—
|
—
|
(47
|
)
|
—
|
1,307
|
0.4
|
4,498
|
2.2
|
|||||||||||
|
Total Casualty
|
27,753
|
18.3
|
38,218
|
58.0
|
75,617
|
24.6
|
98,879
|
47.6
|
||||||||||||
|
Specialty
|
||||||||||||||||||||
|
Financial
|
3,949
|
2.6
|
—
|
—
|
19,599
|
6.4
|
—
|
—
|
||||||||||||
|
Health
|
14,652
|
9.7
|
10,460
|
15.8
|
48,421
|
15.8
|
37,049
|
17.8
|
||||||||||||
|
Medical malpractice
|
—
|
—
|
—
|
—
|
(1,929
|
)
|
(0.6
|
)
|
1,033
|
0.5
|
||||||||||
|
Workers’ compensation
|
8,550
|
5.7
|
2,557
|
3.9
|
14,011
|
4.5
|
16,098
|
7.7
|
||||||||||||
|
Total Specialty
|
27,151
|
18.0
|
13,017
|
19.7
|
80,102
|
26.1
|
54,180
|
26.0
|
||||||||||||
|
$
|
151,247
|
100.0
|
%
|
$
|
65,983
|
100.0
|
%
|
$
|
307,091
|
100.0
|
%
|
$
|
207,901
|
100.0
|
%
|
|||||
|
Three months ended
September 30, 2010
|
Three months ended
September 30, 2009
|
Nine months ended
September 30, 2010
|
Nine months ended
September 30, 2009
|
|||||||||||||||||
|
($ in thousands)
|
($ in thousands)
|
($ in thousands)
|
($ in thousands)
|
|||||||||||||||||
|
USA
|
$
|
140,940
|
93.2
|
%
|
$
|
62,238
|
94.3
|
%
|
$
|
268,299
|
87.4
|
%
|
$
|
182,053
|
87.6
|
%
|
||||
|
Worldwide
(2)
|
10,307
|
6.8
|
3,745
|
5.7
|
38,792
|
12.6
|
24,103
|
11.6
|
||||||||||||
|
Caribbean
|
—
|
—
|
—
|
—
|
—
|
—
|
1,745
|
0.8
|
||||||||||||
|
$
|
151,247
|
100.0
|
%
|
$
|
65,983
|
100.0
|
%
|
$
|
307,091
|
100.0
|
%
|
$
|
207,901
|
100.0
|
%
|
|||||
|
September 30, 2010
|
June 30, 2010
|
March 31, 2010
|
December 31, 2009
|
September 30, 2009
|
|||||||||||||
|
($ in thousands, except per share and share amounts)
|
|||||||||||||||||
|
Basic adjusted and fully diluted adjusted book value per share numerator:
|
|||||||||||||||||
|
Total shareholders' equity (GAAP)
|
$
|
766,800
|
$
|
735,264
|
$
|
716,694
|
$
|
729,238
|
$
|
648,677
|
|||||||
|
Less: Non-controlling interest in joint venture
|
(30,784
|
) |
(29,471
|
) |
(29,517
|
)
|
(30,597
|
)
|
(8,111
|
)
|
|||||||
|
Basic adjusted book value per share numerator
|
$
|
736,016
|
$
|
705,793
|
$
|
687,177
|
$
|
698,641
|
$
|
640,566
|
|||||||
|
Add: Proceeds from in-the-money options issued and outstanding
|
16,590
|
16,590
|
16,590
|
16,623
|
16,031
|
||||||||||||
|
Fully diluted adjusted book value per share numerator
|
$
|
752,606
|
$
|
722,383
|
$
|
703,767
|
$
|
715,264
|
$
|
656,597
|
|||||||
|
Basic adjusted and fully diluted adjusted book value per share denominator:
|
|||||||||||||||||
|
Ordinary shares issued and outstanding for basic adjusted book value per share denominator
|
36,455,784
|
36,451,784
|
36,415,902
|
36,318,842
|
36,308,842
|
||||||||||||
|
Add: In-the-money stock options issued and outstanding
|
1,419,000
|
1,419,000
|
|
1,419,000
|
1,421,340
|
1,406,340
|
|||||||||||
|
Fully diluted adjusted book value per share denominator
|
37,874,784
|
37,870,784
|
37,834,902
|
37,740,182
|
37,715,182
|
||||||||||||
|
Basic adjusted book value per share
|
$
|
20.19
|
$
|
19.36
|
$
|
18.87
|
$
|
19.24
|
$
|
17.64
|
|||||||
|
Fully diluted adjusted book value per share
|
$
|
19.87
|
$
|
19.07
|
$
|
18.60
|
$
|
18.95
|
$
|
17.41
|
|||||||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
|||||||||||||||||||||||
|
($ in thousands)
|
($ in thousands)
|
|||||||||||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||||||||||
|
Frequency
|
$
|
144,889
|
95.8
|
%
|
$
|
62,238
|
94.3
|
%
|
$
|
283,950
|
92.5
|
%
|
$ |
|
176,084
|
84.7
|
%
|
|||||||
|
Severity
|
6,358
|
4.2
|
3,745
|
5.7
|
23,141
|
7.5
|
31,817
|
15.3
|
||||||||||||||||
|
Total
|
$
|
151,247
|
100.0
|
%
|
$
|
65,983
|
100.0
|
%
|
$
|
307,091
|
100.0
|
%
|
$ |
|
207,901
|
100.0
|
%
|
|||||||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
|||||||||||||||||||||||||
|
($ in thousands)
|
($ in thousands)
|
|||||||||||||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||||||||||||
|
Frequency
|
$
|
141,250
|
95.7
|
%
|
$
|
59,493
|
94.3
|
%
|
$
|
275,722
|
92.3
|
%
|
$
|
166,262
|
84.3
|
%
|
||||||||||
|
Severity
|
6,358
|
4.3
|
3,596
|
5.7
|
23,141
|
7.7
|
30,914
|
15.7
|
||||||||||||||||||
|
Total
|
$
|
147,608
|
100.0
|
%
|
$
|
63,089
|
100.0
|
%
|
$
|
298,863
|
100.0
|
%
|
$
|
197,176
|
100.0
|
%
|
||||||||||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
|||||||||||||||||||||||||
|
($ in thousands)
|
($ in thousands)
|
|||||||||||||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||||||||||||
|
Frequency
|
$
|
72,684
|
91.5
|
%
|
$
|
47,176
|
83.3
|
%
|
$
|
161,295
|
87.6
|
%
|
$
|
117,208
|
77.0
|
%
|
||||||||||
|
Severity
|
6,717
|
8.5
|
9,481
|
16.7
|
22,823
|
12.4
|
34,989
|
23.0
|
||||||||||||||||||
|
Total
|
$
|
79,401
|
100.0
|
%
|
$
|
56,657
|
100.0
|
%
|
$
|
184,118
|
100.0
|
%
|
$
|
152,197
|
100.0
|
%
|
||||||||||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
|||||||||||||||||||||||||||
|
($ in thousands)
|
($ in thousands)
|
|||||||||||||||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||||||||||||||
|
Frequency
|
|
$ |
49,610
|
98.7
|
%
|
|
$ |
30,517
|
88.1
|
%
|
$
|
110,724
|
96.3
|
%
|
$
|
71,226
|
80.6
|
%
|
||||||||||
|
Severity
|
647
|
1.3
|
4,126
|
11.9
|
4,212
|
3.7
|
17,160
|
19.4
|
||||||||||||||||||||
|
Total
|
|
$ |
50,257
|
100.0
|
%
|
|
$ |
34,643
|
100.0
|
%
|
$
|
114,936
|
100.0
|
%
|
$
|
88,386
|
100.0
|
%
|
||||||||||
|
Three months ended
September 30, 2010
|
Three months ended
September 30, 2009
|
|||||||||||||||||||||||
|
Gross
|
Ceded
|
Net
|
Gross
|
Ceded
|
Net
|
|||||||||||||||||||
|
($ in thousands)
|
||||||||||||||||||||||||
|
Losses paid (recovered)
|
$
|
55,189
|
$ |
(770
|
)
|
$ |
54,419
|
$
|
18,889
|
$
|
(185
|
)
|
$
|
18,704
|
||||||||||
|
Change in reserves
|
(3,595
|
)
|
(567
|
)
|
(4,162
|
)
|
16,081
|
(142
|
)
|
15,939
|
||||||||||||||
|
Total
|
$
|
51,594
|
$ |
(1,337
|
)
|
$ |
50,257
|
$
|
34,970
|
$
|
(327
|
)
|
$
|
34,643
|
||||||||||
|
Nine months ended
September 30, 2010
|
Nine months ended
September 30, 2009
|
|||||||||||||||||||||||
|
Gross
|
Ceded
|
Net
|
Gross
|
Ceded
|
Net
|
|||||||||||||||||||
|
($ in thousands)
|
||||||||||||||||||||||||
|
Losses paid (recovered)
|
$
|
95,069
|
$ |
(1,720
|
)
|
$ |
93,349
|
$
|
36,079
|
$
|
(2,868
|
)
|
$
|
33,211
|
||||||||||
|
Change in reserves
|
23,835
|
(2,248
|
)
|
21,587
|
50,164
|
5,011
|
55,175
|
|||||||||||||||||
|
Total
|
$
|
118,904
|
$ |
(3,968
|
)
|
$ |
114,936
|
$
|
86,243
|
$
|
2,143
|
$
|
88,386
|
|||||||||||
|
§
|
Adverse loss development of $9.1 million based on data received from the client and our quarterly reserve analysis relating to 2008 and 2009 motor liability contracts, both currently in run-off;
|
|
§
|
Adverse loss development of $3.4 million based on data received from the client and our quarterly reserve analysis, relating to California wildfires on a 2007 casualty clash contract, resulting in losses being reserved at the full contract limit;
|
|
§
|
Adverse loss development of $3.0 million on a 2007 multi-year professional liability excess of loss contract, based on data receive from the client and our quarterly reserve analysis;
|
|
§
|
Elimination of $1.9 million of reserves held on a medical malpractice contract commuted during 2010;
|
|
§
|
Favorable loss development of $1.6 million in aggregate, on two catastrophe contracts based on data received from the client and our quarterly reserve analysis;
|
|
§
|
Adverse loss development of $1.2 million on a 2008 professional liability excess of loss contract, based on data received from the client and our quarterly reserve analysis; and
|
|
§
|
Favorable loss development of $1.1 million in aggregate, on two 2007 professional liability excess of loss contracts, based on data received from the client and our quarterly reserve analysis.
|
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
|||||||||||||||||||||||||
|
($ in thousands)
|
($ in thousands)
|
|||||||||||||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||||||||||||
|
Frequency
|
$
|
27,799
|
96.5
|
%
|
$
|
16,193
|
91.1
|
%
|
$
|
57,370
|
95.3
|
%
|
$
|
43,809
|
94.0
|
%
|
||||||||||
|
Severity
|
1,008
|
3.5
|
1,574
|
8.9
|
2,813
|
4.7
|
2,782
|
6.0
|
||||||||||||||||||
|
Total
|
$
|
28,807
|
100.0
|
%
|
$
|
17,767
|
100.0
|
%
|
$
|
60,183
|
100.0
|
%
|
$
|
46,591
|
100.0
|
%
|
||||||||||
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
||||||||
|
($ in thousands)
|
($ in thousands)
|
||||||||
|
2010
|
2009
|
2010
|
2009
|
||||||
|
Realized gains (losses) and movement in unrealized gains (losses), net
|
$
|
41,983
|
$
|
39,648
|
$
|
55,133
|
$
|
170,846
|
|
|
Interest, dividend and other investment income
|
3,636
|
2,997
|
14,449
|
12,725
|
|||||
|
Interest, dividend and other investment expenses
|
(4,806
|
)
|
(3,570
|
) |
(16,010
|
) |
(11,006
|
) | |
|
Investment advisor compensation
|
(6,932
|
)
|
(6,447
|
) |
(13,890
|
) |
(23,898
|
) | |
|
Net investment income
|
$
|
33,881
|
$
|
32,628
|
$
|
39,682
|
$
|
148,667
|
|
|
Nine months ended
September 30, 2010
|
Nine months ended
September 30, 2009
|
|||||||||||||||||||||||
|
Frequency
|
Severity
|
Total
|
Frequency
|
Severity
|
Total
|
|||||||||||||||||||
|
Loss ratio
|
68.7
|
% |
18.5
|
% |
62.4
|
% |
60.8
|
%
|
49.0
|
% |
58.1
|
% | ||||||||||||
|
Acquisition cost ratio
|
35.6
|
% |
12.3
|
% |
32.7
|
% |
37.4
|
%
|
8.0
|
% |
30.6
|
% | ||||||||||||
|
Composite ratio
|
104.3
|
% |
30.8
|
% |
95.1
|
% |
98.2
|
% |
57.0
|
% |
88.7
|
% | ||||||||||||
|
Internal expense ratio
|
6.3
|
% |
9.1
|
% | ||||||||||||||||||||
|
Combined ratio
|
101.4
|
% |
97.8
|
% | ||||||||||||||||||||
|
September 30, 2010
|
December 31, 2009
|
|||||||||||||||||||||||
|
Case
Reserves
|
IBNR
|
Total
|
Case
Reserves
|
IBNR
|
Total
|
|||||||||||||||||||
|
($ in thousands)
|
||||||||||||||||||||||||
|
Frequency
|
$
|
47,609
|
$
|
67,240
|
$
|
114,849
|
$
|
19,704
|
$
|
69,166
|
$
|
88,870
|
||||||||||||
|
Severity
|
19,240
|
27,091
|
46,331
|
20,472
|
28,018
|
48,490
|
||||||||||||||||||
|
Total
|
$
|
66,849
|
$
|
94,331
|
$
|
161,180
|
$
|
40,176
|
$
|
97,184
|
$
|
137,360
|
||||||||||||
|
Zone
|
Single Event
Loss
|
Aggregate
Loss
|
||||||
|
($ in thousands)
|
||||||||
|
United States
(1)
|
$
|
99,906 |
$
|
118,843 | ||||
|
Europe
|
57,113 | 57,113 | ||||||
|
Japan
|
69,613 | 69,613 | ||||||
|
Rest of the world
|
49,613 | 49,613 | ||||||
|
Maximum Aggregate
|
99,906 | 118,843 | ||||||
|
(1)
|
Includes the Caribbean
|
|
Less than
1 year
|
1-3 years
|
3-5 years
|
More than
5 years
|
Total
|
||||||||||||||||
|
($ in thousands)
|
||||||||||||||||||||
|
Operating lease obligations
(1)
|
$
|
276
|
$ |
552
|
$ |
552
|
$ |
760
|
$ |
2,140
|
||||||||||
|
Specialist service agreement
|
791
|
675
|
—
|
—
|
1,466
|
|||||||||||||||
|
Private equity investments
(2)
|
10,011
|
10,011
|
||||||||||||||||||
|
Loss and loss adjustment expense reserves
(3)
|
73,729 | 56,472 | 24,643 | 6,336 | 161,180 | |||||||||||||||
|
$
|
84,807 | $ | 57,699 | $ | 25,195 | $ | 7,096 | $ | 174,797 | |||||||||||
| (1) | Reflects our contractual obligations pursuant to the July 9, 2008 lease agreement as described below. |
|
(2)
|
As of September 30, 2010, we had made commitments to invest a total of $23.4 million in private investments. As of September 30, 2010, we had invested $13.4 million of this amount, and our remaining commitments to these investments were $10.0 million. Given the nature of these investments, we are unable to determine with any degree of accuracy when the remaining commitment will be called. Therefore, for purposes of the above table, we have assumed that all commitments with no fixed payment schedules will be made within one year. Under our investment guidelines, in effect as of the date hereof, no more than 10% of the assets in the investment portfolio may be held in private equity securities without specific approval from the Board of Directors.
|
|
(3)
|
Due to the nature of our reinsurance operations the amount and timing of the cash flows associated with our reinsurance contractual liabilities will fluctuate, perhaps materially, and, therefore, are highly uncertain.
|
|
10% increase in U.S. dollar
|
10% decrease in U.S. dollar
|
||||||||||||||
|
Foreign Currency
|
Change in
fair value
|
Change in fair value as % of investment portfolio
|
Change in
fair value
|
Change in fair value as % of investment portfolio
|
|||||||||||
|
($ in thousands)
|
|||||||||||||||
|
Chinese Yuan
|
$
|
9,068
|
1.0
|
%
|
$
|
(408
|
)
|
0.0
|
%
|
||||||
|
Euro
|
(4,779
|
)
|
(0.5
|
)
|
4,915
|
0.5
|
|||||||||
|
Indian Rupee
|
1,395
|
0.2
|
(1,395
|
)
|
(0.2
|
)
|
|||||||||
|
Japanese Yen
|
9,563
|
1.0
|
(5,062
|
)
|
(0.5
|
)
|
|||||||||
|
Swiss Franc
|
(1,262
|
)
|
(0.1
|
)
|
1,262
|
0.1
|
|||||||||
|
Other
|
(623
|
)
|
(0.1
|
)
|
623
|
0.1
|
|||||||||
|
Total
|
$
|
13,362
|
1.5
|
% | $ |
(65
|
)
|
0.0
|
%
|
||||||
|
100 basis point increase
in interest rates
|
100 basis point decrease
in interest rates
|
||||||||||||
|
Change in
fair value
|
Change in fair value as % of investment portfolio
|
Change in
fair value
|
Change in fair value as % of investment portfolio
|
||||||||||
|
($ in thousands)
|
|||||||||||||
|
Debt instruments
|
$
|
(66
|
)
|
(0.0
|
)%
|
$ |
66
|
0.0
|
%
|
||||
|
Credit default swaps
|
45
|
0.0
|
(45
|
)
|
0.0
|
||||||||
|
Interest rate options
|
7,057
|
0.8
|
(2,683
|
)
|
(0.3
|
)
|
|||||||
|
Net exposure to interest rate risk
|
$
|
7,036
|
0.8
|
% | $ |
(2,662
|
)
|
(0.3
|
)%
|
||||
|
10.1
|
Letter of Credit Agreement, dated August 20, 2010, between Greenlight Reinsurance, Ltd. and Citibank Europe plc.
|
| 10.2 | Master Reimbursement Agreement dated August 20, 2010, between Greenlight Reinsurance, Ltd. and Citibank Europe plc. |
| 10.3 | Reinsurance Deposit Agreement, dated August 20, 2010, between Greenlight Reinsurance, Ltd. and Citibank Europe plc. |
|
10.4
|
Amended and Restated Agreement, effective as of August 31, 2010, between Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, Ltd., and DME Advisors, LP.
|
| 12.1 | Ratio of Earnings to Fixed Charges and Preferred Share Dividends |
|
31.1
|
Certification of the Chief Executive Officer filed hereunder pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
31.2
|
Certification of the Chief Financial Officer filed hereunder pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
32.1
|
Certification of the Chief Executive Officer filed hereunder pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
32.2
|
Certification of the Chief Financial Officer filed hereunder pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
GREENLIGHT CAPITAL RE, LTD.
|
||
|
(Registrant)
|
||
|
/s/ Leonard Goldberg
|
||
|
Name:
|
Leonard Goldberg
|
|
|
Title:
|
Chief Executive Officer
|
|
|
Date:
|
November 2, 2010
|
|
|
/s/ Tim Courtis
|
||
| Name: | Tim Courtis | |
|
Title:
|
Chief Financial Officer
|
|
|
Date:
|
November 2, 2010
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|